KARO BIO AB

Karo Bio AB is a biopharmaceutical company that specializes in utilizing nuclear receptors for the development of pharmaceuticals targeting metabolic diseases, such as dyslipidemia, diabetes, inflammation and various diseases affecting women’s health. The Company’s product development portfolio includes Eprotirome, a drug against dyslipidemia; ER-beta selective compounds, against depression, inflammation, cancer, pain and women’s diseases and […]